Laura Brege
CIK 1365619 · EVP, Corporate Affairs · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.88M
Companies
11
Total Filings
110
Lifetime Open-Market Net
-$16.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Director | 30,120 | $22.99 | $692.5K | -$1.24M | 21 | 2026-06-12 |
| ACAD | Director | 23,202 | $21.09 | $489.3K | -$5.19M | 31 | 2026-06-01 |
| MIRM | Director | 15,703 | $99.34 | $1.56M | -$1.15M | 9 | 2025-09-12 |
| EWTX | Director | — | $34.83 | — | $0 | 4 | 2025-06-18 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 0 | — | — | $0 | 7 | 2020-07-02 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Director | — | $15.50 | — | $0 | 7 | 2019-05-31 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 13,500 | — | — | $0 | 5 | 2018-07-30 |
| DCTH | Director | 11,678 | $11.72 | $136.9K | $0 | 3 | 2014-07-09 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | EVP, Corporate Affairs | 45,574 | — | — | -$8.85M | 20 | 2011-10-17 |
| ANGIOTECH PHARMACEUTICALS INC (ANPI) Delisted | Director | — | — | — | $0 | 2 | 2009-12-14 |
| ANGIOTECH PHARMACEUTICALS INC (JRT) Delisted | Director | — | — | — | $0 | 1 | 2008-12-10 |
Recent Filings · Page 11 of 11
110 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-12-10 | ANGIOTECH PHARMACEUTICALS INC (JRT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-11-10 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | — | -$182.0K | EDGAR |
| 2008-07-17 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | — | -$275.8K | EDGAR |
| 2008-06-17 | ACAD | Grant (A) | — | $0 | EDGAR |
| 2008-05-05 | ACAD | Exer (M) | — | $0 | EDGAR |
| 2008-04-16 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | — | -$222.2K | EDGAR |
| 2008-04-02 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | +2,666 | -$100.7K | EDGAR |
| 2008-01-16 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | — | -$443.1K | EDGAR |
| 2007-08-14 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | — | -$797.0K | EDGAR |
| 2007-04-02 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
Showing 101–110 of 110
Prev
Page 11 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.